Literature DB >> 1417120

Cellular immunity to cartilage proteoglycans: relevance to the pathogenesis of ankylosing spondylitis.

P Jobanputra1, E H Choy, G H Kingsley, J Sieper, A A Palacios-Boix, D Heinegård, G S Panayi.   

Abstract

Cellular immunity to cartilage proteoglycans may be responsible for sustaining chronic inflammation in ankylosing spondylitis. This hypothesis was examined by measuring peripheral blood and synovial fluid mononuclear cell proliferation in five preparations of human cartilage proteoglycan monomer in vitro. Peripheral blood mononuclear cells from 25 patients and synovial fluid mononuclear cells from five patients were compared with those from normal and disease control subjects matched for age. No significant differences were found between the three groups. This suggests that autoimmune responses to cartilage proteoglycans are unlikely to play a significant part in the pathogenesis of ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417120      PMCID: PMC1004803          DOI: 10.1136/ard.51.8.959

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Metalloproteinases and cartilage proteoglycan depletion in chronic arthritis. Comparison of antigen-induced and polycation-induced arthritis.

Authors:  B Henderson; E R Pettipher; G Murphy
Journal:  Arthritis Rheum       Date:  1990-02

2.  Isolation of proteoglycan-specific T lymphocytes from patients with ankylosing spondylitis.

Authors:  K Mikecz; T T Glant; M Baron; A R Poole
Journal:  Cell Immunol       Date:  1988-03       Impact factor: 4.868

3.  Interleukin 2 responsive T cell clones from rheumatoid and normal subjects: proliferative responses to connective tissue elements.

Authors:  W A Ofosu-Appiah; R J Warrington; J A Wilkins
Journal:  Clin Immunol Immunopathol       Date:  1989-02

4.  Articular responses to purified cartilage proteoglycans.

Authors:  R J Boniface; P R Cain; C H Evans
Journal:  Arthritis Rheum       Date:  1988-02

5.  Heterogeneity of proteoglycans extracted before and after collagenase treatment of human articular cartilage. II. Variations in composition with age and tissue source.

Authors:  R Kuijer; R J van de Stadt; G P van Kampen; M H de Koning; E van de Voorde-Vissers; J K van der Korst
Journal:  Arthritis Rheum       Date:  1986-10

6.  Immunopathologic role of proteoglycan antigens in rheumatoid joint disease.

Authors:  T Glant; J Csongor; T Szücs
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

7.  The role of immunity to cartilage proteoglycan in adjuvant arthritis. Intravenous injection of bovine proteoglycan enhances adjuvant arthritis.

Authors:  R F Van Vollenhoven; A Soriano; P E McCarthy; R L Schwartz; F C Garbrecht; G J Thorbecke; G W Siskind
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

8.  Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis.

Authors:  N A Andriopoulos; J Mestecky; E J Miller; E L Bradley
Journal:  Arthritis Rheum       Date:  1976 May-Jun

9.  Cellular sensitivity to collagen in rheumatoid arthritis.

Authors:  D E Trentham; R A Dynesius; R E Rocklin; J R David
Journal:  N Engl J Med       Date:  1978-08-17       Impact factor: 91.245

Review 10.  Cellular immune responses to cartilage components in rheumatoid arthritis and osteoarthritis: a review and report of a study.

Authors:  L H Sigal; S L Johnston; P E Phillips
Journal:  Clin Exp Rheumatol       Date:  1988 Jan-Mar       Impact factor: 4.473

View more
  4 in total

Review 1.  Cytokines and the immunopathology of the spondyloarthropathies.

Authors:  J Braun; J Sieper
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

2.  A longitudinal study on an autoimmune murine model of ankylosing spondylitis.

Authors:  T Bárdos; Z Szabó; M Czipri; C Vermes; M Tunyogi-Csapó; R M Urban; K Mikecz; T T Glant
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

3.  T-cell responses to versican in ankylosing spondylitis.

Authors:  Tae-Jong Kim; Tae-Hwan Kim; Hyun-Joo Lee; Bitnara Lee; A Robin Poole; Robert D Inman
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

4.  Inhibition of Complement Retards Ankylosing Spondylitis Progression.

Authors:  Chaoqun Yang; Peipei Ding; Qingkai Wang; Long Zhang; Xin Zhang; Jianquan Zhao; Enjie Xu; Na Wang; Jianfeng Chen; Guang Yang; Weiguo Hu; Xuhui Zhou
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.